Information:
Error:
ID
19018
Description
Effects of GCP on Prostate Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00269555
Link
https://clinicaltrials.gov/show/NCT00269555
Keywords
Versions (1)
- 11/30/16 11/30/16 -
Uploaded on
November 30, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00269555
Eligibility Prostate Cancer NCT00269555
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00269555
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Gender | Prostate carcinoma
Item
participants must be male and have a pathological diagnosis of prostate cancer.
boolean
C0079399 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
C0600139 (UMLS CUI [2])
Therapeutic procedure | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
no treatment (surgery [rrp], radiation, or hormones) prior to study entry.
boolean
C0087111 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Patient Decision | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
the patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery [rrp], radiation, or hormones) for the next six months.
boolean
C0030705 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0679006 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Prostate specific antigen measurement
Item
psa between 2.0 and 10.0 ng/ml.
boolean
C0201544 (UMLS CUI [1])
Raised prostate specific antigen | Patient Surveillance Duration
Item
if psa is >10.0, patient must have been on active surveillance for 12 months prior to study initiation.
boolean
C0178415 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0038842 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,1])
C0038842 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Allergy to soy | Hypersensitivity Soy product
Item
no known allergy to soy or soy products.
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Genistein Unit per Gram per Day Dietary Supplements
Item
the patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (otc supplements).
boolean
C0061202 (UMLS CUI [1,1])
C2349072 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
C2349072 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Prostate carcinoma
Item
no pathological documentation of prostate cancer.
boolean
C0600139 (UMLS CUI [1])
Allergy to soy | Hypersensitivity Soy product
Item
allergy to soy or soy products
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Therapeutic procedure Prostate carcinoma
Item
prior history of treatment for prostate cancer.
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])